Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-08 Purchase(A) |
2023-02-17 6:40 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
27,000 | $1.8929 | $51,108 | 435,514 (Indirect) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:30 pm |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
1,238 | $1.61 | $1,993 | 2,738 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
38,032 | $1.921 | $73,059 | 38,032 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
27,000 | $1.8929 | $51,108 | 152,000 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
15,985 | $1.878 | $30,020 | 40,985 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
13,358 | $1.8761 | $25,061 | 13,358 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
5,568 | $1.7964 | $10,002 | 5,568 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
17,328 | $0.9 | 174,230 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
43,443 | $0.9 | 373,556 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
12,175 | $0.9 | 135,126 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
19,748 | $0.9 | 186,657 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
20,153 | $0.9 | 202,009 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,108 | $0 | 416,999 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
104,516 | $0 | 191,558 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
88,822 | $0 | 147,301 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
112,790 | $0 | 206,405 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
125,717 | $0 | 222,162 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Gaeta Renee Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 08:45 am |
N/A 2033-06-07 |
Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director |
28,480 | $0 | 28,480 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:10 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:05 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:00 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 4:50 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 4:45 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:31 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
90,877 | $0 | 90,877 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
195,906 | $0 | 220,906 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
90,877 | $0 | 92,377 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:29 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
58,479 | $0 | 58,479 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:26 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu See Remarks |
73,684 | $0 | 73,684 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:45 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:45 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:42 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |